Fragmin® (dalteparin sodium)

Choose Fragmin®

There is a wealth of experience with Fragmin® and a broad range of indications for your patients

Established clinical experience:

  • To date more than 85 million Fragmin® syringes, vials and ampoules have been used in the UK1

Broad range of clinical indications2–7

  • Extended treatment of symptomatic venous thromboembolism  (VTE) and prevention of its recurrence in patients with solid tumours
  • Peri- and post-operative surgical thromboprophylaxis
  • Thromboprophylaxis in patients bedridden due to a medical condition*
  • Treatment of VTE
  • Unstable angina and non-Q wave MI, administered concurrently with aspirin
  • Prevention of clotting in the extracorporeal circulation during haemodialysis or haemofiltration†

*Including, but not limited to: congestive cardiac failure (NYHA class III or IV), acute respiratory failure or acute infection, who also have a predisposing risk factor for VTE such as age over 75 years, obesity, cancer or previous history of VTE.~
†In patients with chronic renal insufficiency or acute renal failure.

Simple dosing regimen:

  • Once or twice daily dosing using colour-coded syringes and other presentations2-7
Fragmin® Guidelines



1. Data on File (IMS Data).
2. Fragmin SmPC [Surgical Thromboprophylaxis (2,500 IU and 5,000 IU syringes)]. Available at: and
3. Fragmin SmPC [Medical Thromboprophylaxis (5,000 IU syringes)]. Available at:
4. Fragmin SmPC [Treatment of VTE (7,500-18,000 IU syringes, 10,000 IU/1 ml ampoules, 100,000 IU/4 ml Multidose Vial)]. Available at:
5. Fragmin SmPC [Unstable Angina (Graduated syringe 10,000 IU/ml solution for injection, 10,000 IU/1 ml ampoule, 7,500 IU)]. Available at:
6. Fragmin SmPC [Haemodialysis/Haemofiltration (10,000 IU/1 ml & 10,000 IU/4 ml ampoules)]. Available at: and
7. Fragmin SmPC [Extended Treatment in Oncology (5,000-18,000 IU syringes)]. Available at:

PP-FRA-GBR-0142.  June 2019